China Pharma Holdings, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2010
Total Assets: $131.8M
Liabilities Breakdown FY2010
Total Liabilities: $13.8M
Asset Breakdown
Total Assets: $131.8M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $3.7M | 2.8% |
| Accounts Receivable | $61.9M | 47.0% |
| Inventory | $20.4M | 15.5% |
| Property, Plant & Equipment | $6.4M | 4.8% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $3.5M | 2.7% |
| Other Assets | $35.8M | 27.2% |
Liabilities Breakdown
Total Liabilities: $13.8M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $4.9M | 35.7% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $8.9M | 64.3% |